YourSix VSaaS Startup Profile And Axis Partnership

By Zach Segal, Published May 13, 2021, 10:21am EDT (Info+)

YourSix is a US VSaaS startup, most known for its ongoing partnership with Axis, that touts substantial growth and an anti-lock-in approach.

IPVM Image

With Axis ending its Guardian VSaaS offering, Axis has been recommending YourSix to US customers.

IPVM examines the company based on an interview with YourSix CTO and principal Jacob Hengel.

**********

********** ******* ** **** *** ******* selling ** ****, ** * ***** managed ***** ******** *** **** ****** and ****** *******.

******* **** **** **** ** *********, up **** ** ** *** ***** of ****.

******* ** ****-****** *** **** *** rely ** ******* ******* *** *** open ** ** ** ** ***** sense **** **** ****:

** ** *** **** ** ******* funding ***** *** ** **** **** to ************ **** ** ********* *** self-fund. ** ********* ************* **** ** and ** ** *** *** ********* and *** ** *** ****** *** business *** ** **** ** **** is ***** ** **** **** ** to ****** *** **** **** ******* of *** ********* *** ********. *** short **** ** * ***** ***** to *** ************.

**** **-****** ******* **** *** ***** Hengel ***** ********** ** *******:

Revenue *** *******

******* **** **** **** ****** $*** in ******* ** **** ** **** $8m ** **** **** **% ****** from **** ******** *** **% ****** from ***** *******. **** ******** **** without ********* ** $** * ****** a ***** *** * ******* ***** storage ******** **** ** ********** $** a ****** * ***** ********* ** YourSix. ********* **** ******** ********** ********* and ********** ********, *** ******* ******* to *** ** ******** **** ***** deals *** ** ****** ******* ***********. YourSix **** ****** ** ***** ****** by ****** **** ******* ******** *** that **** *** ****** ~*,*** ******* a *****.

90+% ******* ** **; **** ** ***********

**+% ** ***** ******** ** ** the ** *** **** ** ***** international ******** ***** **** ** ******** selling ** ****** *********, *** **** plan ** ********* ** ****** ****, YourSix **** ****. ******* **** **** they ******* * ****** ** ********** in ****** *** **** *********** ******* and ********** ************* ** ****** *** this *********.

Guardian ******/************ **** ****

******* ***** **** ** ** **** and *** ****** ** ******** ** a ****** ** ******** **********. **** told **** **** **** ***** **** camera ***** *** ******* **** ******** help ***** ***** *** *****. **** added **** ****** ** **** ************ *** ** ******* **** ********* who **** ********** ***** ***** ******* YourSix *** ***** ******** ********** ******* to *** ********* *** ********** **** Guardian:

*** ****** ** ******** **** ** the ********** ** ******* ****** *** product *** ****** **** ** *&* spending. ** *** *** *** ******** a ****** ** ********* *** *** working **** **** **** ******** **** use ** **** **** ******** ******* of *** ******* ***********.

**** *************** *** **** ***** ******* ** the **** ** **** *** ****(*** ***** *** *** ***** *** in ****).

**** ********* *** ******** ****** ******* include:

IPVM Image

** **** **:

IPVM Image

Cannabis, *****-***** **** **** *********

******** ** *******’* **** ********* ********, in **** *** ** *** ******* of ****** *** ********** ********** *** to *****-**. ***** ******* ********* *** multi-site **** ******* ***********, ** ** sites **** ** ******* **. * site **** ***, ******* **** ****.

Product ********

******* ***** ******* ***** *** **************** *******,****** *******, ********/********, ******* *** **** *** ******* or *******, ***** **** *** ** AWS. **** *** ******* *** ** set ** ** * ******* **** Axis ***-***** *** ******* *** ** scaled ******. ***** ******* ** ** optional ***-**, *** ****** ***** ** a ******’* **** ** ******* ** preset *******, ** ******* *** ****** how **** **** ** ******* **** want. ******* *** ** ****** *****-***** but ******* ********** ********* *** ** cards ** ** *********** ******.

*******, *** **** ** ******* / servers **-**** **** ****** ********** *** customers **** ****** ****** ****** ** limited ******** *********.

Cyber ******** *****

******* **** **** **** ********* *************, spending ** ***** ********* ****** ** compliance ** ****. ******* ****** ********** at ***** *****, ****-******* **** ********* on *******, *** ******** ****** *** suspicious ******** (**** ** ******* ** from * *** ********), ********* ** CTO ***** ******. **** **** **** they ****** ******* ***-********* ** ************* *** *** ********** as **** ****** **** ******** **-******* deployments, *** ** ***** ***** ** security, ********, ***-***** ********, *** ********** spending. **** *** ***** ******* ** instantly **** ******* ***** **** ***** bugs ****** **** ******. ******* ***** they *** ***** ************ *** *** ********* ********** ****** ****** *********, ***** **** said *** *** **** **** *** most *********** ** ***-***** ** ** themselves.

Health ********** ********* ******** *******

****** ********** *** ******** ******* *** included **** **** ********. ******* **** IPVM ***** ****** ********** ******** **** in ** ************** ******* *** ******* out ***** ****** *****, ***** **** automated ******** *******, ***** ******** * large ****** ** ******* ******.

*********

******* ***** **** ***** *********, ********** with **** ******** ********* *********/******, *** can ** ********** **** ***** *******, mentioning********,***** ************,**********,*** ********* **** **** ****** ******* analytics. ***** ****** **** **** **** typically ****** **** ********* **** ******** with *** ***** ********* *** ******* only ******** *********** *******.

******* **** **** ******* **** ********* such ** ****** ********* *** *** facial *********** *** **** ** ********* their ************* **-***** ******** ** *** future:

** ******* * ******* ** **** analytics ******** ** *** ******** ***** (object *********, ***). ** *** ****** in **** ********* **** ** *** and ******* **** ****.

******* ***** **** ******* **** ********* and ******* **** *** *** **** option ** ******** ******* ** *** bandwidth/cost ******* **** ******* ********* *** YourSix.

Axis ****, *** ****** *** ****** ** ** ***

******* ********* **** ******** **** *******, both ******* **** *** *****-********* ******** like * ***** ***** ** **** on ********* *** ***-***** ***** *********** allowing *** *-****** ***-***, ** **** as *********** ***** **** *** * **** reputation*** ******* ******** **** *** *******. YourSix **** **** *** ****** ** another ************, **** ** ****** ***** they ******* * **** **********, ** *******, *** ********* ******** many *******, *** ***** ***** **** with ********* ** *****.

Always ** ******* ********, **** ******** **** *****

******* **** **** **** **** ** through *** ******* *** **** **** not ****** ***** **’* ** ******:

** **** ***** ** * ****** sales ******* ** **** ** * own *** ******** *** **** *** decisions

******* **** **** **** *********** *** are ********** **** ***** *********, ** integrators **** ************ *********** *** ************, or **** ******* **********, *** **** when ********* ***** ** ******* ***** alone *** **** ** ***** ** engage ** ****** *****.

**** ** ******* ***** ********** **** ********** ******* ******** **** *** ********** ***** **** **** ***********.

**********

******* ***** *********** **** *** **** funding ** **** ** ******* ******* potential *** ****** ** ******* *******.

****** ********** / **** *********, ******* *** *** **** *******, makes *** **** *** ******** (***** those ****** ****/**** ******** ** ****) while ***** ****** ******* ******* (***** YourSix **** *** ****-** ********, ** is ******* ** **** *****).

****** ***** ***, *******, *** *******, YourSix ****** *** **** ******* ******* than ***** ***** **** ********* ** well ** ****** **** ******* ** smaller ****.

***** ****'* ***** **** *** *******, YourSix *** * **** **********. **** will ** ******** ** *** *** company ******* ** ****** **** ******* to * ****** ********** ********, ***** almost ********* **** ******* *** **** funding, ******* *******, *** ****** ************* to ******* **** *** **** ***** of ******* *********** ****** *** *****.

Comments (2)

**** ****' ********* ******** ** ****** control, * ***'* **** ** *** how ** ** ******* ******** ** that *****. ***** **** **, * have ***** *** **** ****** *** team. **'* * ***** ******* ******** they're ******.

Agree
Disagree
Informative: 1
Unhelpful
Funny

**** ** * ***** **** ****/****. We ******** **** ******* ******** ********* who ***'* **** ****** * ******* but *** ******* *** *** ******** products ** *** ***. **** ***** becoming ********* ********* *** ***** **** may ** * ***. *** ************ with **** ** *** ** ***** as ** **** *** ** **** is, **************, *** ***** * **** heard ** *******.

Agree
Disagree
Informative
Unhelpful
Funny: 1
Login to read this IPVM report.
Why do I need to log in?
IPVM conducts reporting, tutorials and software funded by subscriber's payments enabling us to offer the most independent, accurate and in-depth information.
Loading Related Reports